Rev 10/11/2026 · Master Clinical Training Suite

DLP 22: Ethan Hunt

Complete Clinical Lifecycle: Patient Portal Registration, Annual Procedure Consent Renewal Screening (SAFE-ALLERGY-DOCUMENTED), Arrival Clock Reset, Check-In Safety Clearance, Visible Rooming, Clinical Intake Vitals, Botox Cosmetic Anatomical Neurotoxin Therapy, and Square Terminal POS Checkout.

Scenario 22 SAFE-ALLERGY-DOCUMENTED Dr. Colette Marchand, MD Square Terminal POS ($800.00) 100% Pass Validated

DLP 01: Kailani DLP 14: Marcus Vance DLP 15: Devon Chen DLP 16: Amara Okafor DLP 17: Sophia Valenti DLP 18: Liam Gallagher DLP 21: Sierra Washington DLP 22: Ethan Hunt

Clinical Safety Governance

Scenario Code: DLP-SCR-22

Governing Rule: SAFE-ALLERGY-DOCUMENTED (No allergy status documented in chart)

Clinical Protocol: When an intake registration is submitted without documented known drug allergies or explicit NKDA attestation, the clinical safety engine quarantines the card at Intake Incomplete until front-desk staff documents allergy status and obtains clinician affirmation on camera.

Patient & Provider Demographics

Patient Persona: Ethan Hunt (Male, DOB: 1990-05-15, Age 36)

Address: 1224 NW 50th St, Oklahoma City, OK 73118

Phone: (405) 555-0122 | SSN Last 4: 4022

Attending Clinician: Dr. Colette Marchand, MD

Clinical Coordinator: Sarah Jenkins | Clinical Assistant: Alex Morgan, PA-C

Documented Treatment & Settlement

Primary Treatment: Restylane L 1.0mL with Micro-Cannula Technique (1 syringe, $800.00)

Adjunctive Service: Comprehensive Aesthetic Consultation & Evaluation ($0.00)

Tender Method: Square Terminal POS Device (In-Person)

Transaction Settlement: Approved #TX-73118-POS | Balance Due: $0.00

Audit Invariant: Patient card retained in Lane 12 (Completed) for statutory census reconciliation.